Table 1.

Donor and patient characteristics according to transplantation arm

Bone marrow (n = 118)Peripheral blood (n = 109)
Donor age, y44  (13-74)43  (17-67)
Patient age, y44  (19-64)45  (19-64)
CMV-seronegative patient and donor40  (34%)30  (28%)
CML55  (47%)54  (49%)
 CP-149  (42%)46  (42%)
 > CP-1, AP6  (5%)8  (7%)
AML43  (36%)39  (36%)
 CR-133  (28%)29  (27%)
 > CR-19  (8%)9  (8%)
MDS20  (17%)16  (15%)
Early disease* 87  (74%)78  (72%)
Advanced disease 31  (26%)31  (28%)
  • Data are presented as median (range) or n (%).

  • CP-1 indicates first chronic phase; AP, accelerated phase; and CR-1, first complete remission.

  • * Early disease: AML CR-1, CML CP-1, refractory anemia, and refractory anemia with ringed sideroblasts.

  • Advanced disease: AML beyond CR-1, CML beyond CP-1 and AP, refractory anemia with excess blasts, and refractory anemia with excess blasts in transformation.

  • One patient with AML for whom disease status at transplantation was not known.